Dixon Technologies Gains Analyst Support Ahead of Expected Vivo Joint Venture Approval

Dixon Technologies (India) Ltd. remains a focal point for investors as major global brokerages maintain bullish outlooks on the company, citing a proposed joint venture with smartphone manufacturer Vivo as a key growth catalyst. Macquarie has reiterated its 'Outperform' rating with a price target of ₹15,000, implying approximately 17% upside from recent trading levels, while JPMorgan retained an 'Overweight' rating with a ₹12,700 target. Both brokerages view the Vivo partnership and the PLI 2.0 scheme as significant drivers for the company's medium-term expansion and localisation strategy.

Dixon and Vivo entered into a binding term sheet in December 2024 to establish a joint venture focused on manufacturing electronic products, including smartphones. The transaction remains subject to definitive agreements, pre-closing conditions, and statutory approvals. According to reports, an inter-ministerial panel has granted in-principle approval to the venture, with final clearance expected from India's Ministry of Electronics and Information Technology (MeitY) this month. However, Dixon has officially clarified to the National Stock Exchange that regulatory approvals for the joint venture are still pending as of the latest disclosure.

During its fourth-quarter earnings call, Dixon guided for FY27 revenue of ₹560 billion, excluding potential contributions from both the Vivo joint venture and the PLI 2.0 scheme, signalling substantial upside potential once these initiatives materialise. The company's stock has gained approximately 24% since March 30 and is up 19% over the past month, driven partly by approval expectations.

However, not all analysts share the optimistic sentiment. CLSA downgraded Dixon Technologies to 'Underperform' from 'Hold' earlier in the week, arguing that the recent stock rally has been excessive relative to approval uncertainties. CLSA cited concerns including expected organic volume declines in FY27 due to elevated memory prices affecting smartphone demand, delays in backward integration projects, and moderate long-term growth prospects as the domestic smartphone market approaches saturation. Among 32 analysts covering the stock, 22 maintain 'Buy' ratings, three recommend 'Hold', and seven have 'Sell' ratings.

Dixon's shares closed Wednesday's session 4.97% higher at ₹12,832.55, reflecting ongoing investor interest as stakeholders await regulatory clarity on the transformative Vivo partnership.